Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
BRAF Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale.
Cancers (Basel). 2019 Sep 17;11(9):1381. doi: 10.3390/cancers11091381.
Cancers (Basel). 2019.
PMID: 31533235
Free PMC article.
Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients.
Ruiz de Porras V, Bystrup S, Cabrero-de Las Heras S, Musulén E, Palomero L, Alonso MH, Nieto R, Arango D, Moreno V, Queralt C, Manzano JL, Layos L, Bugés C, Martinez-Balibrea E.
Ruiz de Porras V, et al.
Cancers (Basel). 2019 Oct 11;11(10):1540. doi: 10.3390/cancers11101540.
Cancers (Basel). 2019.
PMID: 31614664
Free PMC article.
Item in Clipboard
Cite
Cite